HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
601	858 VANDENBERG SR, HERMAN MM, RUBINSTEIN LJ EMBRYONAL CENTRAL NEUROEPITHELIAL TUMORS - CURRENT CONCEPTS AND FUTURE CHALLENGES CANCER AND METASTASIS REVIEWS. 1987; 5 (4): 343-364	12	20	2	233
602	10972 Planel E, Sun XY, Takashima A Role of GSK-3 beta in Alzheimer's disease pathology DRUG DEVELOPMENT RESEARCH. 2002 JUL; 56 (3): 491-510	16	38	104	233
603	11293 Ray SK, Dixon CE, Banik NL Molecular mechanisms in the pathogenesis of traumatic brain injury HISTOLOGY AND HISTOPATHOLOGY. 2002 OCT; 17 (4): 1137-1152	9	39	28	233
604	16975 Papassotiropoulos A, Fountoulakis M, Dunckley T, Stephan DA, Reiman EM Genetics, transcriptomics, and proteomics of Alzheimer's disease JOURNAL OF CLINICAL PSYCHIATRY. 2006 APR; 67 (4): 652-670	7	28	26	233
605	17863 Sultana R, Perluigi M, Butterfield DA Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: Insights into mechanism of neuro degeneration from redox proteomics ANTIOXIDANTS & REDOX SIGNALING. 2006 NOV-DEC; 8 (11-12): 2021-2037	15	64	53	233
606	18807 Abraham NG, Asija A, Drummond G, Peterson S Heme oxygenase-1 gene therapy: Recent advances and therapeutic applications CURRENT GENE THERAPY. 2007 APR; 7 (2): 89-108	1	35	7	233
607	25798 Rodolfo C, Ciccosanti F, Di Giacomo G, Piacentini M, Fimia GM Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases EXPERT REVIEW OF PROTEOMICS. 2010 AUG; 7 (4): 519-542	0	0	76	233
608	2403 PUSZKIN S, PERRY D, LI SW, HANSON V NEURONAL PROTEIN NP185 IS DEVELOPMENTALLY REGULATED, INITIALLY EXPRESSED DURING SYNAPTOGENESIS, AND LOCALIZED IN SYNAPTIC TERMINALS MOLECULAR NEUROBIOLOGY. 1992 SUM-FAL; 6 (2-3): 253-283	0	4	6	232
609	6410 Hense J, Kolkenbrock S, Schutte J Merkel cell carcinoma: Case reports and review of the literature TUMORDIAGNOSTIK & THERAPIE. 1998 OCT; 19 (5): 123-137	0	1	15	232
610	7610 Coons SW, Ashby LS Pathology of intracranial neoplasms NEUROIMAGING CLINICS OF NORTH AMERICA. 1999 NOV; 9 (4): 615-+	0	5	14	232
#	Date / Author / Journal	LCS	GCS	LCR	CR
611	9567 Sayre LM, Smith MA, Perry G Chemistry and biochemistry of oxidative stress in neurodegenerative disease CURRENT MEDICINAL CHEMISTRY. 2001 JUN; 8 (7): 721-738	58	234	46	232
612	11287 Jackson M, Llado J, Rothstein JD Therapeutic developments in the treatment of amyotrophic lateral sclerosis EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2002 OCT; 11 (10): 1343-1364	7	15	38	232
613	15680 Riaz SS, Bradford HF Factors involved in the determination of the neurotransmitter phenotype of developing neurons of the CNS: Applications in cell replacement treatment for Parkinson's disease PROGRESS IN NEUROBIOLOGY. 2005 JUL; 76 (4): 257-278	2	8	14	232
614	20161 Cotman CW, Head E The Canine (Dog) Model of Human Aging and Disease: Dietary, Environmental and Immunotherapy Approaches JOURNAL OF ALZHEIMERS DISEASE. 2008; 15 (4): 685-707	5	13	36	232
615	20433 Zlokovic BV The blood-brain barrier in health and chronic neurodegenerative disorders NEURON. 2008 JAN 24; 57 (2): 178-201	23	224	17	232
616	24381 Butterfield DA, Hardas SS, Lange MLB Oxidatively Modified Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and Alzheimer's Disease: Many Pathways to Neurodegeneration JOURNAL OF ALZHEIMERS DISEASE. 2010; 20 (2): 369-393	0	1	24	232
617	26538 Costa J, Gomes C, de Carvalho M Diagnosis, Pathogenesis and Therapeutic Targets in Amyotrophic Lateral Sclerosis CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 DEC; 9 (6): 764-778	1	1	47	232
618	26800 Dobrian AD, Lieb DC, Cole BK, Taylor-Fishwick DA, Chakrabarti SK, et al. Functional and pathological roles of the 12-and 15-lipoxygenases PROGRESS IN LIPID RESEARCH. 2011 JAN; 50 (1): 115-131	0	0	6	232
619	5349 Giannakopoulos P, Hof PR, Michel JP, Guimon J, Bouras C Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts BRAIN RESEARCH REVIEWS. 1997 OCT; 25 (2): 217-245	26	87	33	231
620	5651 Saugstad LF Cerebral lateralisation and rate of maturation INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY. 1998 JAN; 28 (1): 37-62	2	28	2	231
#	Date / Author / Journal	LCS	GCS	LCR	CR
621	9115 Fricker-Gates RA, Lundberg C, Dunnett SB Neural transplantation: Restoring complex circuitry in the striatum RESTORATIVE NEUROLOGY AND NEUROSCIENCE. 2001; 19 (1-2): 119-138	7	18	3	231
622	10228 Blits B, Boer GJ, Verhaagen J Pharmacological, cell, and gene therapy strategies to promote spinal cord regeneration CELL TRANSPLANTATION. 2002; 11 (6): 593-613	0	26	11	231
623	17947 Olanow CW, McNaught KS Ubiquitin-proteasome system and Parkinson's disease MOVEMENT DISORDERS. 2006 NOV; 21 (11): 1806-1823	16	45	95	231
624	23251 Shepherd C, McCann H, Halliday GM Variations in the neuropathology of familial Alzheimer's disease ACTA NEUROPATHOLOGICA. 2009 JUL; 118 (1): 37-52	4	7	60	231
625	23991 Butterfield DA, Lange MLB Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism JOURNAL OF NEUROCHEMISTRY. 2009 NOV; 111 (4): 915-933	2	7	32	231
626	25352 Ramkumar HL, Zhang J, Chan CC Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) PROGRESS IN RETINAL AND EYE RESEARCH. 2010 MAY; 29 (3): 169-190	0	3	7	231
627	25655 Tisato F, Marzano C, Porchia M, Pellei M, Santini C Copper in Diseases and Treatments, and Copper-Based Anticancer Strategies MEDICINAL RESEARCH REVIEWS. 2010 JUL; 30 (4): 708-749	0	7	7	231
628	262 BRAAK E ON THE STRUCTURE OF THE HUMAN STRIATE AREA ADVANCES IN ANATOMY EMBRYOLOGY AND CELL BIOLOGY. 1982; 77: 1-87	0	13	10	230
629	4123 Lee MK, Cleveland DW Neuronal intermediate filaments ANNUAL REVIEW OF NEUROSCIENCE. 1996; 19: 187-217	101	240	68	230
630	8730 Lewen A, Matz P, Chan PH Free radical pathways in CNS injury JOURNAL OF NEUROTRAUMA. 2000 OCT; 17 (10): 871-890	45	328	12	230
#	Date / Author / Journal	LCS	GCS	LCR	CR
631	9180 Lanctot KL, Herrmann N, Mazzotta P Role of serotonin in the behavioral and psychological symptoms of dementia JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES. 2001 WIN; 13 (1): 5-21	3	53	1	230
632	21323 Wang Q, Johnson JL, Agar NYR, Agar JN Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival PLOS BIOLOGY. 2008 JUL; 6 (7): Art. No. e170	0	23	37	230
633	23925 Perrot R, Eyer J Neuronal intermediate filaments and neurodegenerative disorders BRAIN RESEARCH BULLETIN. 2009 OCT 28; 80 (4-5): 282-295	3	3	100	230
634	24486 Possin KL Visual spatial cognition in neurodegenerative disease NEUROCASE. 2010; 16 (6): 466-487	0	0	52	230
635	26370 Bandyopadhyay S, Huang XD, Lahiri DK, Rogers JT Novel drug targets based on metallobiology of Alzheimer's disease EXPERT OPINION ON THERAPEUTIC TARGETS. 2010 NOV; 14 (11): 1177-1197	0	0	41	230
636	26831 Perrin RJ, Craig-Schapiro R, Malone JP, Shah AR, Gilmore P, et al. Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease PLOS ONE. 2011 JAN 12; 6 (1): Art. No. e16032	0	0	30	230
637	864 TYLER KL, MCPHEE DA MOLECULAR AND GENETIC-ASPECTS OF THE PATHOGENESIS OF VIRAL-INFECTIONS OF THE CENTRAL NERVOUS-SYSTEM CRITICAL REVIEWS IN NEUROBIOLOGY. 1987; 3 (3): 221-243	0	5	3	229
638	1470 MATTSON MP CELLULAR SIGNALING MECHANISMS COMMON TO THE DEVELOPMENT AND DEGENERATION OF NEUROARCHITECTURE - A REVIEW MECHANISMS OF AGEING AND DEVELOPMENT. 1989 NOV; 50 (2): 103-157	11	75	3	229
639	2296 JOACHIM CL, SELKOE DJ THE SEMINAL ROLE OF BETA-AMYLOID IN THE PATHOGENESIS OF ALZHEIMER- DISEASE ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1992 SPR; 6 (1): 7-34	23	146	12	229
640	16435 Ziani-Cherif C, Mostefa-Kara B, Brixi-Gormat FZ Gamma-secretase as a pharmacological target in Alzheimer disease research: When, why and how? CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4313-4335	1	7	31	229
#	Date / Author / Journal	LCS	GCS	LCR	CR
641	22841 Prabhakar R Computational insights into the development of novel therapeutic strategies for Alzheimer's disease FUTURE MEDICINAL CHEMISTRY. 2009 APR; 1 (1): 119-135	0	1	13	229
642	24865 Meyer AK, Maisel M, Hermann A, Stirl K, Storch A Restorative approaches in Parkinson's Disease: Which cell type wins the race? JOURNAL OF THE NEUROLOGICAL SCIENCES. 2010 FEB 15; 289 (1-2): 93-103	0	2	37	229
643	26128 Anselme K, Davidson P, Popa AM, Giazzon M, Liley M, et al. The interaction of cells and bacteria with surfaces structured at the nanometre scale ACTA BIOMATERIALIA. 2010 OCT; 6 (10): 3824-3846	0	0	1	229
644	9520 Goff DC, Heckers S, Freudenreich O Schizophrenia MEDICAL CLINICS OF NORTH AMERICA. 2001 MAY; 85 (3): 663-+	0	18	19	228
645	13686 Poletti A The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons FRONTIERS IN NEUROENDOCRINOLOGY. 2004 APR; 25 (1): 1-26	5	32	28	228
646	14794 Katsel PL, Davis KL, Haroutunian V Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 63. 2005; 63: 41-82	13	26	33	228
647	14972 Brandt R, Hundelt M, Shahani N Tau alteration and neuronal degeneration in tauopathies: mechanisms and models BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 331-354	45	65	160	228
648	17920 Miu AC, Benga O Aluminum and Alzheimer's disease: A new look JOURNAL OF ALZHEIMERS DISEASE. 2006 NOV; 10 (2-3): 179-201	4	18	30	228
649	18355 Eriksen JL, Janus CG Plaques, tangles, and memory loss in mouse models of neurodegeneration BEHAVIOR GENETICS. 2007 JAN; 37 (1): 79-100	12	36	48	228
650	22639 Clark J, Simon DK Transcribe to Survive: Transcriptional Control of Antioxidant Defense Programs for Neuroprotection in Parkinson's Disease ANTIOXIDANTS & REDOX SIGNALING. 2009 MAR; 11 (3): 509-528	2	7	26	228
#	Date / Author / Journal	LCS	GCS	LCR	CR
651	23280 Banerjee R, Starkov AA, Beal MF, Thomas B Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 651-663	9	23	45	228
652	24437 Frisardi V, Panza F, Seripa D, Imbimbo BP, Vendemiale G, et al. Nutraceutical Properties of Mediterranean Diet and Cognitive Decline: Possible Underlying Mechanisms JOURNAL OF ALZHEIMERS DISEASE. 2010; 22 (3): 715-740	0	0	18	228
653	26360 Perrone MG, Scilimati A, Simone L, Vitale P Selective COX-1 Inhibition: A Therapeutic Target to be Reconsidered CURRENT MEDICINAL CHEMISTRY. 2010 NOV; 17 (32): 3769-3805	0	0	3	228
654	1880 STREHLER BL WHERE IS THE SELF - A NEUROANATOMICAL THEORY OF CONSCIOUSNESS SYNAPSE. 1991 JAN; 7 (1): 44-91	0	21	7	227
655	9517 Clippingdale AB, Wade JD, Barrow CJ The amyloid-beta peptide and its role in Alzheimer's disease JOURNAL OF PEPTIDE SCIENCE. 2001 MAY; 7 (5): 227-249	6	46	24	227
656	19381 Dwork AJ, Mancevski B, Rosoklija G White matter and cognitive function in schizophrenia INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2007 AUG; 10 (4): 513-536	2	13	29	227
657	21319 Schneider A, Mandelkow E Tau-based treatment strategies in neurodegenerative diseases NEUROTHERAPEUTICS. 2008 JUL; 5 (3): 443-457	14	20	135	227
658	21704 Pienaar IS, Daniels WMU, Gotz J Neuroproteomics as a promising tool in Parkinson's disease research JOURNAL OF NEURAL TRANSMISSION. 2008 OCT; 115 (10): 1413-1430	2	6	70	227
659	22370 Lu J, Goh SJ, Tng PYL, Deng YY, Ling EA, et al. Systemic inflammatory response following acute traumatic brain injury FRONTIERS IN BIOSCIENCE-LANDMARK. 2009 JAN; 14: 3795-3813	0	4	11	227
660	26620 Wadsworth JDF, Asante EA, Collinge J Review: Contribution of transgenic models to understanding human prion disease NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 DEC; 36 (7): 576-597	0	0	39	227
#	Date / Author / Journal	LCS	GCS	LCR	CR
661	5560 Price DL, Tanzi RE, Borchelt DR, Sisodia SS Alzheimer's disease: Genetic studies and transgenic models ANNUAL REVIEW OF GENETICS. 1998; 32: 461-493	66	231	30	226
662	6018 Teplow DB Structural and kinetic features of amyloid beta-protein fibrillogenesis AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS. 1998 JUN; 5 (2): 121-142	35	173	17	226
663	10325 Higuchi M, Lee VMY, Trojanowski JQ Tau and axonopathy in neurodegenerative disorders NEUROMOLECULAR MEDICINE. 2002; 2 (2): 131-150	46	46	137	226
664	11103 Ellison D Classifying the medulloblastoma: insights from morphology and molecular genetics NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2002 AUG; 28 (4): 257-282	27	91	50	226
665	15031 Tatard VM, Menei P, Benoit JP, Montero-Menei CN Combining polymeric devices and stem cells for the treatment of neurological disorders: A promising therapeutic approach CURRENT DRUG TARGETS. 2005 FEB; 6 (1): 81-96	1	10	27	226
666	16491 Guzhova I, Margulis B Hsp70 chaperone as a survival factor in cell pathology INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 254. 2006; 254: 101-149	0	21	20	226
667	19687 Swerdlow RH Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? NEUROBIOLOGY OF AGING. 2007 OCT; 28 (10): 1465-1480	8	20	42	226
668	24414 Daulatzai MA Conversion of Elderly to Alzheimer's Dementia: Role of Confluence of Hypothermia and Senescent Stigmata - the Plausible Pathway JOURNAL OF ALZHEIMERS DISEASE. 2010; 21 (4): 1039-1063	0	0	19	226
669	25472 Han I, You YM, Kordower JH, Brady ST, Morfini GA Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features JOURNAL OF NEUROCHEMISTRY. 2010 JUN; 113 (5): 1073-1091	0	0	22	226
670	26525 Teixeira AL, Barbosa IG, Diniz BS, Kummer A Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function BIOMARKERS IN MEDICINE. 2010 DEC; 4 (6): 871-887	0	0	16	226
#	Date / Author / Journal	LCS	GCS	LCR	CR
671	90 MARKOWITSCH HJ, PRITZEL M COMPARATIVE ANALYSIS OF PREFRONTAL LEARNING FUNCTIONS IN RATS, CATS, AND MONKEYS PSYCHOLOGICAL BULLETIN. 1977; 84 (5): 817-837	13	82	1	225
672	1546 MIETTINEN M IMMUNOHISTOCHEMISTRY OF SOFT-TISSUE TUMORS - POSSIBILITIES AND LIMITATIONS IN SURGICAL PATHOLOGY PATHOLOGY ANNUAL. 1990; 25: 1-36	0	27	15	225
673	5373 Lindstrom J Nicotinic acetylcholine receptors in health and disease MOLECULAR NEUROBIOLOGY. 1997 OCT; 15 (2): 193-222	4	274	1	225
674	10593 Pitz S, Moll R Intermediate-filament expression in ocular tissue PROGRESS IN RETINAL AND EYE RESEARCH. 2002 MAR; 21 (2): 241-262	0	14	17	225
675	16998 Mattson MP, Magnus T Ageing and neuronal vulnerability NATURE REVIEWS NEUROSCIENCE. 2006 APR; 7 (4): 278-294	25	146	41	225
676	19021 Adams CE, Stevens KE Evidence for a role of nicotinic acetylcholine receptors in schizophrenia FRONTIERS IN BIOSCIENCE. 2007 MAY 1; 12: 4755-4772	1	10	8	225
677	19616 Shi QL, Gibson GE Oxidative stress and transcriptional regulation in Alzheimer disease ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): 276-291	9	41	31	225
678	20383 Jahn TR, Radford SE Folding versus aggregation: Polypeptide conformations on competing pathways ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2008 JAN 1; 469 (1): 100-117	1	47	19	225
679	25053 Aboukhatwa M, Dosanjh L, Luo Y Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease MOLECULAR NEURODEGENERATION. 2010 MAR 12; 5: Art. No. 10	0	1	9	225
680	26021 Ebrahim-Habibi A, Morshedi D, Rezaei-Ghaleh N, Sabbaghian M, Nemat-Gorgani M Protein-Protein Interactions Leading to Aggregation: Perspectives on Mechanism, Significance and Control JOURNAL OF THE IRANIAN CHEMICAL SOCIETY. 2010 SEP; 7 (3): 521-544	0	0	28	225
#	Date / Author / Journal	LCS	GCS	LCR	CR
681	26337 Bueler H Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease APOPTOSIS. 2010 NOV; 15 (11): 1336-1353	0	3	34	225
682	26535 Badiola N, Suarez-Calvet M, Lleo A Tau Phosphorylation and Aggregation as a Therapeutic Target in Tauopathies CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 DEC; 9 (6): 727-740	0	0	134	225
683	16715 Feldman HH, Gauthier S, Chertkow H, Conn DK, Freedman M, et al. Progress in clinical neurosciences: Canadian guidelines for the development of antidementia therapies: A conceptual summary CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. 2006 FEB; 33 (1): 6-26	2	12	18	224
684	23272 Karten B, Peake KB, Vance JE Mechanisms and consequences of impaired lipid trafficking in Niemann- Pick type C1-deficient mammalian cells BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. 2009 JUL; 1791 (7): 659-670	0	16	19	224
685	24261 Butterfield SM, Lashuel HA Amyloidogenic Protein Membrane Interactions: Mechanistic Insight from Model Systems ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2010; 49 (33): 5628-5654	0	1	38	224
686	25715 Baumer D, Ansorge O, Almeida M, Talbot K The role of RNA processing in the pathogenesis of motor neuron degeneration EXPERT REVIEWS IN MOLECULAR MEDICINE. 2010 JUL 20; 12: Art. No. e21	0	0	42	224
687	9030 Lea PM, Faden AI Traumatic brain injury: Developmental differences in glutamate receptor response and the impact on treatment MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS. 2001; 7 (4): 235-248	2	14	10	223
688	12224 Ray SK, Hogan EL, Banik NL Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors BRAIN RESEARCH REVIEWS. 2003 MAY; 42 (2): 169-185	10	83	19	223
689	19644 Hedlund E, Hefferan MP, Marsala M, Isacson O Cell therapy and stem cells in animal models of motor neuron disorders EUROPEAN JOURNAL OF NEUROSCIENCE. 2007 OCT; 26 (7): 1721-1737	4	25	35	223
690	23039 Fatemi SH, Folsom TD The Neurodevelopmental Hypothesis of Schizophrenia, Revisited SCHIZOPHRENIA BULLETIN. 2009 MAY; 35 (3): 528-548	0	33	21	223
#	Date / Author / Journal	LCS	GCS	LCR	CR
691	24430 Jimenez JS Protein-DNA Interaction at the Origin of Neurological Diseases: A Hypothesis JOURNAL OF ALZHEIMERS DISEASE. 2010; 22 (2): 375-391	0	0	58	223
692	25829 Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, et al. Posttreatment prognosis of patients with esthesioneuroblastoma Clinical article JOURNAL OF NEUROSURGERY. 2010 AUG; 113 (2): 340-351	0	0	13	223
693	2592 RAFFIONI S, BRADSHAW RA, BUXSER SE THE RECEPTORS FOR NERVE GROWTH-FACTOR AND OTHER NEUROTROPHINS ANNUAL REVIEW OF BIOCHEMISTRY. 1993; 62: 823-850	3	104	12	222
694	9438 Mahadik SP, Evans D, Lal H Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2001 APR; 25 (3): 463-493	8	85	5	222
695	9996 Strong MJ Progress in clinical neurosciences: The evidence for ALS as a multisystems disorder of limited phenotypic expression CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. 2001 NOV; 28 (4): 283-298	16	35	25	222
696	14750 Ricard-Blum S, Ruggiero F, van der Rest M The collagen superfarmily COLLAGEN. 2005; 247: 35-84	0	16	3	222
697	16432 Sigurdsson EM Immunotherapy for conformational diseases CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (20): 2569-2585	7	12	17	222
698	16771 Tycko R Molecular structure of amyloid fibrils: insights from solid-state NMR QUARTERLY REVIEWS OF BIOPHYSICS. 2006 FEB; 39 (1): 1-55	7	125	14	222
699	16869 Lledo PM, Alonso M, Grubb MS Adult neurogenesis and functional plasticity in neuronal circuits NATURE REVIEWS NEUROSCIENCE. 2006 MAR; 7 (3): 179-193	10	322	7	222
700	24117 Cuny GD Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions CURRENT PHARMACEUTICAL DESIGN. 2009 DEC; 15 (34): 3919-3939	1	4	39	222

Date / Author / Journal

LCS

GCS

LCR

601

858 VANDENBERG SR, HERMAN MM, RUBINSTEIN LJ

EMBRYONAL CENTRAL NEUROEPITHELIAL TUMORS - CURRENT CONCEPTS AND FUTURE CHALLENGES

CANCER AND METASTASIS REVIEWS. 1987; 5 (4): 343-364

233

602

10972 Planel E, Sun XY, Takashima A

Role of GSK-3 beta in Alzheimer's disease pathology

DRUG DEVELOPMENT RESEARCH. 2002 JUL; 56 (3): 491-510

104

233

603

11293 Ray SK, Dixon CE, Banik NL

Molecular mechanisms in the pathogenesis of traumatic brain injury

HISTOLOGY AND HISTOPATHOLOGY. 2002 OCT; 17 (4): 1137-1152

233

604

16975 Papassotiropoulos A, Fountoulakis M, Dunckley T, Stephan DA, Reiman EM

Genetics, transcriptomics, and proteomics of Alzheimer's disease

JOURNAL OF CLINICAL PSYCHIATRY. 2006 APR; 67 (4): 652-670

233

605

17863 Sultana R, Perluigi M, Butterfield DA

Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: Insights into mechanism of neuro degeneration from redox proteomics

ANTIOXIDANTS & REDOX SIGNALING. 2006 NOV-DEC; 8 (11-12): 2021-2037

233

606

18807 Abraham NG, Asija A, Drummond G, Peterson S

Heme oxygenase-1 gene therapy: Recent advances and therapeutic applications

CURRENT GENE THERAPY. 2007 APR; 7 (2): 89-108

233

607

25798 Rodolfo C, Ciccosanti F, Di Giacomo G, Piacentini M, Fimia GM

Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases

EXPERT REVIEW OF PROTEOMICS. 2010 AUG; 7 (4): 519-542

233

608

2403 PUSZKIN S, PERRY D, LI SW, HANSON V

NEURONAL PROTEIN NP185 IS DEVELOPMENTALLY REGULATED, INITIALLY EXPRESSED DURING SYNAPTOGENESIS, AND LOCALIZED IN SYNAPTIC TERMINALS

MOLECULAR NEUROBIOLOGY. 1992 SUM-FAL; 6 (2-3): 253-283

232

609

6410 Hense J, Kolkenbrock S, Schutte J

Merkel cell carcinoma: Case reports and review of the literature

TUMORDIAGNOSTIK & THERAPIE. 1998 OCT; 19 (5): 123-137

232

610

7610 Coons SW, Ashby LS

Pathology of intracranial neoplasms

NEUROIMAGING CLINICS OF NORTH AMERICA. 1999 NOV; 9 (4): 615-+

232

Date / Author / Journal

LCS

GCS

LCR

611

9567 Sayre LM, Smith MA, Perry G

Chemistry and biochemistry of oxidative stress in neurodegenerative disease

CURRENT MEDICINAL CHEMISTRY. 2001 JUN; 8 (7): 721-738

234

232

612

11287 Jackson M, Llado J, Rothstein JD

Therapeutic developments in the treatment of amyotrophic lateral sclerosis

EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2002 OCT; 11 (10): 1343-1364

232

613

15680 Riaz SS, Bradford HF

Factors involved in the determination of the neurotransmitter phenotype of developing neurons of the CNS: Applications in cell replacement treatment for Parkinson's disease

PROGRESS IN NEUROBIOLOGY. 2005 JUL; 76 (4): 257-278

232

614

20161 Cotman CW, Head E

The Canine (Dog) Model of Human Aging and Disease: Dietary, Environmental and Immunotherapy Approaches

JOURNAL OF ALZHEIMERS DISEASE. 2008; 15 (4): 685-707

232

615

20433 Zlokovic BV

The blood-brain barrier in health and chronic neurodegenerative disorders

NEURON. 2008 JAN 24; 57 (2): 178-201

224

232

616

24381 Butterfield DA, Hardas SS, Lange MLB

Oxidatively Modified Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and Alzheimer's Disease: Many Pathways to Neurodegeneration

JOURNAL OF ALZHEIMERS DISEASE. 2010; 20 (2): 369-393

232

617

26538 Costa J, Gomes C, de Carvalho M

Diagnosis, Pathogenesis and Therapeutic Targets in Amyotrophic Lateral Sclerosis

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 DEC; 9 (6): 764-778

232

618

26800 Dobrian AD, Lieb DC, Cole BK, Taylor-Fishwick DA, Chakrabarti SK, et al.

Functional and pathological roles of the 12-and 15-lipoxygenases

PROGRESS IN LIPID RESEARCH. 2011 JAN; 50 (1): 115-131

232

619

5349 Giannakopoulos P, Hof PR, Michel JP, Guimon J, Bouras C

Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts

BRAIN RESEARCH REVIEWS. 1997 OCT; 25 (2): 217-245

231

620

5651 Saugstad LF

Cerebral lateralisation and rate of maturation

INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY. 1998 JAN; 28 (1): 37-62

231

Date / Author / Journal

LCS

GCS

LCR

621

9115 Fricker-Gates RA, Lundberg C, Dunnett SB

Neural transplantation: Restoring complex circuitry in the striatum

RESTORATIVE NEUROLOGY AND NEUROSCIENCE. 2001; 19 (1-2): 119-138

231

622

10228 Blits B, Boer GJ, Verhaagen J

Pharmacological, cell, and gene therapy strategies to promote spinal cord regeneration

CELL TRANSPLANTATION. 2002; 11 (6): 593-613

231

623

17947 Olanow CW, McNaught KS

Ubiquitin-proteasome system and Parkinson's disease

MOVEMENT DISORDERS. 2006 NOV; 21 (11): 1806-1823

231

624

23251 Shepherd C, McCann H, Halliday GM

Variations in the neuropathology of familial Alzheimer's disease

ACTA NEUROPATHOLOGICA. 2009 JUL; 118 (1): 37-52

231

625

23991 Butterfield DA, Lange MLB

Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism

JOURNAL OF NEUROCHEMISTRY. 2009 NOV; 111 (4): 915-933

231

626

25352 Ramkumar HL, Zhang J, Chan CC

Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD)

PROGRESS IN RETINAL AND EYE RESEARCH. 2010 MAY; 29 (3): 169-190

231

627

25655 Tisato F, Marzano C, Porchia M, Pellei M, Santini C

Copper in Diseases and Treatments, and Copper-Based Anticancer Strategies

MEDICINAL RESEARCH REVIEWS. 2010 JUL; 30 (4): 708-749

231

628

262 BRAAK E

ON THE STRUCTURE OF THE HUMAN STRIATE AREA

ADVANCES IN ANATOMY EMBRYOLOGY AND CELL BIOLOGY. 1982; 77: 1-87

230

629

4123 Lee MK, Cleveland DW

Neuronal intermediate filaments

ANNUAL REVIEW OF NEUROSCIENCE. 1996; 19: 187-217

101

240

230

630

8730 Lewen A, Matz P, Chan PH

Free radical pathways in CNS injury

JOURNAL OF NEUROTRAUMA. 2000 OCT; 17 (10): 871-890

328

230

Date / Author / Journal

LCS

GCS

LCR

631

9180 Lanctot KL, Herrmann N, Mazzotta P

Role of serotonin in the behavioral and psychological symptoms of dementia

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES. 2001 WIN; 13 (1): 5-21

230

632

21323 Wang Q, Johnson JL, Agar NYR, Agar JN

Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival

PLOS BIOLOGY. 2008 JUL; 6 (7): Art. No. e170

230

633

23925 Perrot R, Eyer J

Neuronal intermediate filaments and neurodegenerative disorders

BRAIN RESEARCH BULLETIN. 2009 OCT 28; 80 (4-5): 282-295

100

230

634

24486 Possin KL

Visual spatial cognition in neurodegenerative disease

NEUROCASE. 2010; 16 (6): 466-487

230

635

26370 Bandyopadhyay S, Huang XD, Lahiri DK, Rogers JT

Novel drug targets based on metallobiology of Alzheimer's disease

EXPERT OPINION ON THERAPEUTIC TARGETS. 2010 NOV; 14 (11): 1177-1197

230

636

26831 Perrin RJ, Craig-Schapiro R, Malone JP, Shah AR, Gilmore P, et al.

Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease

PLOS ONE. 2011 JAN 12; 6 (1): Art. No. e16032

230

637

864 TYLER KL, MCPHEE DA

MOLECULAR AND GENETIC-ASPECTS OF THE PATHOGENESIS OF VIRAL-INFECTIONS OF THE CENTRAL NERVOUS-SYSTEM

CRITICAL REVIEWS IN NEUROBIOLOGY. 1987; 3 (3): 221-243

229

638

1470 MATTSON MP

CELLULAR SIGNALING MECHANISMS COMMON TO THE DEVELOPMENT AND DEGENERATION OF NEUROARCHITECTURE - A REVIEW

MECHANISMS OF AGEING AND DEVELOPMENT. 1989 NOV; 50 (2): 103-157

229

639

2296 JOACHIM CL, SELKOE DJ

THE SEMINAL ROLE OF BETA-AMYLOID IN THE PATHOGENESIS OF ALZHEIMER- DISEASE

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1992 SPR; 6 (1): 7-34

146

229

640

16435 Ziani-Cherif C, Mostefa-Kara B, Brixi-Gormat FZ

Gamma-secretase as a pharmacological target in Alzheimer disease research: When, why and how?

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4313-4335

229

Date / Author / Journal

641

Computational insights into the development of novel therapeutic strategies for Alzheimer's disease

FUTURE MEDICINAL CHEMISTRY. 2009 APR; 1 (1): 119-135

229

642

24865 Meyer AK, Maisel M, Hermann A, Stirl K, Storch A

Restorative approaches in Parkinson's Disease: Which cell type wins the race?

JOURNAL OF THE NEUROLOGICAL SCIENCES. 2010 FEB 15; 289 (1-2): 93-103

229

643

26128 Anselme K, Davidson P, Popa AM, Giazzon M, Liley M, et al.

The interaction of cells and bacteria with surfaces structured at the nanometre scale

ACTA BIOMATERIALIA. 2010 OCT; 6 (10): 3824-3846

229

644

9520 Goff DC, Heckers S, Freudenreich O

Schizophrenia

MEDICAL CLINICS OF NORTH AMERICA. 2001 MAY; 85 (3): 663-+

228

645

13686 Poletti A

The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons

FRONTIERS IN NEUROENDOCRINOLOGY. 2004 APR; 25 (1): 1-26

228

646

14794 Katsel PL, Davis KL, Haroutunian V

Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease

INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 63. 2005; 63: 41-82

228

647

14972 Brandt R, Hundelt M, Shahani N

Tau alteration and neuronal degeneration in tauopathies: mechanisms and models

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 331-354

160

228

648

17920 Miu AC, Benga O

Aluminum and Alzheimer's disease: A new look

JOURNAL OF ALZHEIMERS DISEASE. 2006 NOV; 10 (2-3): 179-201

228

649

18355 Eriksen JL, Janus CG

Plaques, tangles, and memory loss in mouse models of neurodegeneration

BEHAVIOR GENETICS. 2007 JAN; 37 (1): 79-100

228

650

22639 Clark J, Simon DK

Transcribe to Survive: Transcriptional Control of Antioxidant Defense Programs for Neuroprotection in Parkinson's Disease

ANTIOXIDANTS & REDOX SIGNALING. 2009 MAR; 11 (3): 509-528

228

Date / Author / Journal

LCS

GCS

LCR

651

23280 Banerjee R, Starkov AA, Beal MF, Thomas B

Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 651-663

228

652

24437 Frisardi V, Panza F, Seripa D, Imbimbo BP, Vendemiale G, et al.

Nutraceutical Properties of Mediterranean Diet and Cognitive Decline: Possible Underlying Mechanisms

JOURNAL OF ALZHEIMERS DISEASE. 2010; 22 (3): 715-740

228

653

26360 Perrone MG, Scilimati A, Simone L, Vitale P

Selective COX-1 Inhibition: A Therapeutic Target to be Reconsidered

CURRENT MEDICINAL CHEMISTRY. 2010 NOV; 17 (32): 3769-3805

228

654

1880 STREHLER BL

WHERE IS THE SELF - A NEUROANATOMICAL THEORY OF CONSCIOUSNESS

SYNAPSE. 1991 JAN; 7 (1): 44-91

227

655

9517 Clippingdale AB, Wade JD, Barrow CJ

The amyloid-beta peptide and its role in Alzheimer's disease

JOURNAL OF PEPTIDE SCIENCE. 2001 MAY; 7 (5): 227-249

227

656

19381 Dwork AJ, Mancevski B, Rosoklija G

White matter and cognitive function in schizophrenia

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2007 AUG; 10 (4): 513-536

227

657

21319 Schneider A, Mandelkow E

Tau-based treatment strategies in neurodegenerative diseases

NEUROTHERAPEUTICS. 2008 JUL; 5 (3): 443-457

135

227

658

21704 Pienaar IS, Daniels WMU, Gotz J

Neuroproteomics as a promising tool in Parkinson's disease research

JOURNAL OF NEURAL TRANSMISSION. 2008 OCT; 115 (10): 1413-1430

227

659

22370 Lu J, Goh SJ, Tng PYL, Deng YY, Ling EA, et al.

Systemic inflammatory response following acute traumatic brain injury

FRONTIERS IN BIOSCIENCE-LANDMARK. 2009 JAN; 14: 3795-3813

227

660

26620 Wadsworth JDF, Asante EA, Collinge J

Review: Contribution of transgenic models to understanding human prion disease

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 DEC; 36 (7): 576-597

227

Date / Author / Journal

LCS

GCS

LCR

661

5560 Price DL, Tanzi RE, Borchelt DR, Sisodia SS

Alzheimer's disease: Genetic studies and transgenic models

ANNUAL REVIEW OF GENETICS. 1998; 32: 461-493

231

226

662

6018 Teplow DB

Structural and kinetic features of amyloid beta-protein fibrillogenesis

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS. 1998 JUN; 5 (2): 121-142

173

226

663

10325 Higuchi M, Lee VMY, Trojanowski JQ

Tau and axonopathy in neurodegenerative disorders

NEUROMOLECULAR MEDICINE. 2002; 2 (2): 131-150

137

226

664

11103 Ellison D

Classifying the medulloblastoma: insights from morphology and molecular genetics

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2002 AUG; 28 (4): 257-282

226

665

15031 Tatard VM, Menei P, Benoit JP, Montero-Menei CN

Combining polymeric devices and stem cells for the treatment of neurological disorders: A promising therapeutic approach

CURRENT DRUG TARGETS. 2005 FEB; 6 (1): 81-96

226

666

16491 Guzhova I, Margulis B

Hsp70 chaperone as a survival factor in cell pathology

INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 254. 2006; 254: 101-149

226

667

19687 Swerdlow RH

Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?

NEUROBIOLOGY OF AGING. 2007 OCT; 28 (10): 1465-1480

226

668

24414 Daulatzai MA

Conversion of Elderly to Alzheimer's Dementia: Role of Confluence of Hypothermia and Senescent Stigmata - the Plausible Pathway

JOURNAL OF ALZHEIMERS DISEASE. 2010; 21 (4): 1039-1063

226

669

25472 Han I, You YM, Kordower JH, Brady ST, Morfini GA

Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features

JOURNAL OF NEUROCHEMISTRY. 2010 JUN; 113 (5): 1073-1091

226

670

26525 Teixeira AL, Barbosa IG, Diniz BS, Kummer A

Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function

BIOMARKERS IN MEDICINE. 2010 DEC; 4 (6): 871-887

226

Date / Author / Journal

LCS

GCS

LCR

671

90 MARKOWITSCH HJ, PRITZEL M

COMPARATIVE ANALYSIS OF PREFRONTAL LEARNING FUNCTIONS IN RATS, CATS, AND MONKEYS

PSYCHOLOGICAL BULLETIN. 1977; 84 (5): 817-837

225

672

1546 MIETTINEN M

IMMUNOHISTOCHEMISTRY OF SOFT-TISSUE TUMORS - POSSIBILITIES AND LIMITATIONS IN SURGICAL PATHOLOGY

PATHOLOGY ANNUAL. 1990; 25: 1-36

225

673

5373 Lindstrom J

Nicotinic acetylcholine receptors in health and disease

MOLECULAR NEUROBIOLOGY. 1997 OCT; 15 (2): 193-222

274

225

674

10593 Pitz S, Moll R

Intermediate-filament expression in ocular tissue

PROGRESS IN RETINAL AND EYE RESEARCH. 2002 MAR; 21 (2): 241-262

225

675

16998 Mattson MP, Magnus T

Ageing and neuronal vulnerability

NATURE REVIEWS NEUROSCIENCE. 2006 APR; 7 (4): 278-294

146

225

676

19021 Adams CE, Stevens KE

Evidence for a role of nicotinic acetylcholine receptors in schizophrenia

FRONTIERS IN BIOSCIENCE. 2007 MAY 1; 12: 4755-4772

225

677

19616 Shi QL, Gibson GE

Oxidative stress and transcriptional regulation in Alzheimer disease

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): 276-291

225

678

20383 Jahn TR, Radford SE

Folding versus aggregation: Polypeptide conformations on competing pathways

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2008 JAN 1; 469 (1): 100-117

225

679

25053 Aboukhatwa M, Dosanjh L, Luo Y

Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease

MOLECULAR NEURODEGENERATION. 2010 MAR 12; 5: Art. No. 10

225

680

26021 Ebrahim-Habibi A, Morshedi D, Rezaei-Ghaleh N, Sabbaghian M, Nemat-Gorgani M

Protein-Protein Interactions Leading to Aggregation: Perspectives on Mechanism, Significance and Control

JOURNAL OF THE IRANIAN CHEMICAL SOCIETY. 2010 SEP; 7 (3): 521-544

225

Date / Author / Journal

681

Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease

APOPTOSIS. 2010 NOV; 15 (11): 1336-1353

225

682

26535 Badiola N, Suarez-Calvet M, Lleo A

Tau Phosphorylation and Aggregation as a Therapeutic Target in Tauopathies

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 DEC; 9 (6): 727-740

134

225

683

16715 Feldman HH, Gauthier S, Chertkow H, Conn DK, Freedman M, et al.

Progress in clinical neurosciences: Canadian guidelines for the development of antidementia therapies: A conceptual summary

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. 2006 FEB; 33 (1): 6-26

224

684

23272 Karten B, Peake KB, Vance JE

Mechanisms and consequences of impaired lipid trafficking in Niemann- Pick type C1-deficient mammalian cells

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. 2009 JUL; 1791 (7): 659-670

224

685

24261 Butterfield SM, Lashuel HA

Amyloidogenic Protein Membrane Interactions: Mechanistic Insight from Model Systems

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2010; 49 (33): 5628-5654

224

686

25715 Baumer D, Ansorge O, Almeida M, Talbot K

The role of RNA processing in the pathogenesis of motor neuron degeneration

EXPERT REVIEWS IN MOLECULAR MEDICINE. 2010 JUL 20; 12: Art. No. e21

224

687

9030 Lea PM, Faden AI

Traumatic brain injury: Developmental differences in glutamate receptor response and the impact on treatment

MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS. 2001; 7 (4): 235-248

223

688

12224 Ray SK, Hogan EL, Banik NL

Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors

BRAIN RESEARCH REVIEWS. 2003 MAY; 42 (2): 169-185

223

689

19644 Hedlund E, Hefferan MP, Marsala M, Isacson O

Cell therapy and stem cells in animal models of motor neuron disorders

EUROPEAN JOURNAL OF NEUROSCIENCE. 2007 OCT; 26 (7): 1721-1737

223

690

23039 Fatemi SH, Folsom TD

The Neurodevelopmental Hypothesis of Schizophrenia, Revisited

SCHIZOPHRENIA BULLETIN. 2009 MAY; 35 (3): 528-548

223

Date / Author / Journal

691

Protein-DNA Interaction at the Origin of Neurological Diseases: A Hypothesis

JOURNAL OF ALZHEIMERS DISEASE. 2010; 22 (2): 375-391

223

692

25829 Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, et al.

Posttreatment prognosis of patients with esthesioneuroblastoma Clinical article

JOURNAL OF NEUROSURGERY. 2010 AUG; 113 (2): 340-351

223

693

2592 RAFFIONI S, BRADSHAW RA, BUXSER SE

THE RECEPTORS FOR NERVE GROWTH-FACTOR AND OTHER NEUROTROPHINS

ANNUAL REVIEW OF BIOCHEMISTRY. 1993; 62: 823-850

104

222

694

9438 Mahadik SP, Evans D, Lal H

Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2001 APR; 25 (3): 463-493

222

695

9996 Strong MJ

Progress in clinical neurosciences: The evidence for ALS as a multisystems disorder of limited phenotypic expression

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. 2001 NOV; 28 (4): 283-298

222

696

14750 Ricard-Blum S, Ruggiero F, van der Rest M

The collagen superfarmily

COLLAGEN. 2005; 247: 35-84

222

697

16432 Sigurdsson EM

Immunotherapy for conformational diseases

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (20): 2569-2585

222

698

16771 Tycko R

Molecular structure of amyloid fibrils: insights from solid-state NMR

QUARTERLY REVIEWS OF BIOPHYSICS. 2006 FEB; 39 (1): 1-55

125

222

699

16869 Lledo PM, Alonso M, Grubb MS

Adult neurogenesis and functional plasticity in neuronal circuits

NATURE REVIEWS NEUROSCIENCE. 2006 MAR; 7 (3): 179-193

322

222

700

24117 Cuny GD

Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions

CURRENT PHARMACEUTICAL DESIGN. 2009 DEC; 15 (34): 3919-3939

222

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records